ACTRN12607000418471已完成2 期
In patients with chronic hepatitis C, does treatment with oglufanide disodium reduce viral load from baseline value?
Implicit Bioscience Pty Ltd0 个研究点目标入组 17 人开始时间: 2007年8月17日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Serological evidence of infection with hepatitis C virus (HCV), including anti-HCV antibodies and viral load at least 100 time sgreate tha the lower limit of detection.
排除标准
- •1. Co-infection with hepatitis B or human immunodeficiency virus (HIV)
- •2. Severe liver disease, or liver disease due to other disorders
- •3. Renal, hepatic or bone marrow dysfunction
- •4. Active or suspected cancer or histor of malignancy with high risk of recurrence
- •5. Organ transplant
- •6. Substance abuse
- •7. Women of childbearing potential
研究者
相似试验
已完成
不适用
Spirulina Platensis in the Treatment of Chronic Hepatitis C Virus (HCV) InfectioACTRN12610000958088Abbass Helmy Charity60
已完成
2 期
THE HEP573 STUDY: A randomised, double-blind, placebo-controlled clinical trial of silymarin alone, and silymarin combined with antioxidants in chronic hepatitis CChronic Hepatitis CAlternative and Complementary Medicine - Herbal remediesAlternative and Complementary Medicine - Other alternative and complementary medicineOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12614000966695John Hunter Hospital216
已完成
4 期
CHESS - Curing Hepatitis C: Effect on the Endothelium and cardiovaScular riSk - a pilot single arm trial, assessing the effect of hepatitis C virus (HCV) treatment with 12 weeks of paritaprevir/ritonavir/ombitasvir, dasabuvir +/- ribavirin on endothelial function.Hepatitis C virus infectionEndothelial functionInfection - Other infectious diseasesCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12615001167550John Hunter Hospital16
尚未招募
不适用
Efficacy of antiviral therapy in hepatitis C patients aged 70 years or older: multicenter prospective observational studyChronic hepatitis CJPRN-UMIN000017329R24 Liver Conference516
已完成
不适用
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINEPER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,